Health
Freiburg researchers receive ERC funding to develop and test immunostimulatory drug candidates – News-Medical.net
With the Proof of Concept funding line, the ERC grants recipients of ERC frontier research funds (Starting, Consolidator, Advanced or Synergy grants) with 150.000…
With the Proof of Concept funding line, the ERC grants recipients of ERC frontier research funds (Starting, Consolidator, Advanced or Synergy grants) with 150.000 Euro to develop promising ideas with commercial or societal potential to the proof of concept stage. With this funding, Olaf Groß and his team in the Metabolism and Inflammation Group at the Institute of Neuropathology of the Medical Center – University of Freiburg will test whether a new class of immune activating drugs they discovered…
-
Business22 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News22 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News22 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
General12 hours agoAsian, European stocks nosedive on tariff turmoil